Study offers potential new strategy for use of retinoids against some breast cancers

[News]

Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment -- and breast cancers with higher CK5 expression have poorer prognosis.

More... (http://www.news-medical.net/news/20170726/Study-offers-potential-new-strategy-for-use-of-retinoids-against-some-breast-cancers.aspx)